Friday 6 November 2026
Export ATRC’s income statement to Excel — free account
AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
59.84
1.44
−2.35%
Follow ATRC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 7 | 8 | 8 |
| (2.40%) | (0.97%) | 2.15% | 2.95% | ||
| (1.81%) | (0.74%) | 1.64% | 2.20% | ||
ROIC |
(1.48%) | (0.44%) | 1.92% | 2.61% | |
Return on Tangible Assets |
(4.09%) | (1.64%) | 3.45% | 4.30% | |
Average Days of Receivables |
45.51 | 47.14 | 51.25 | 47.11 | |
Free Cash Flow per Share |
1.01 | 1.11 | 1.09 | 1.08 | |
Free Cash Flow |
48.28 | 53.64 | 53.11 | 52.94 | |
Capital Expenditures |
(9.05) | (10.72) | (11.82) | (15.61) | |
| Other line items | |||||
Cash ROIC |
6.59% | 7.56% | 7.03% | 6.78% | |
Accounts Receivable Turnover |
8.42 | 8.20 | 7.80 | 8.48 | |
Accounts Payable Turnover |
5.31 | 4.83 | 4.39 | 2.60 | |
Inventory Turnover |
1.74 | 1.73 | 1.68 | 1.65 | |
Average Days of Payables |
69.07 | 82.81 | 96.92 | 213.52 | |
Days of Inventory on Hand |
214.20 | 219.88 | 226.89 | 232.32 | |
Tax Rate |
0.13 | 0.41 | (0.13) | (0.08) | |
Research and Development Expense of Revenue |
18.56% | 18.28% | 17.21% | 18.19% | |
Selling, General and Administrative Expense of Revenue |
58.19% | 57.87% | 56.82% | 55.67% | |
Share Based Compensation of Revenue |
8.36% | 8.39% | 8.30% | 8.02% | |
Interest Coverage |
(1.61) | (0.51) | 2.29 | 2.95 | |
Operating CF/Net income |
(5.01) | (14.01) | 6.15 | 4.61 | |
Depreciation/Fixed assets |
0.54 | 0.53 | 0.50 | 0.00 | |
Capex/Depreciation |
(0.43) | (0.51) | (0.55) | 0.00 | |
Revenue per Share |
11.19 | 11.42 | 11.70 | 12.06 | |
Operating CF per Share |
1.20 | 1.33 | 1.33 | 1.40 | |
Capex per Share |
(0.19) | (0.22) | (0.24) | (0.32) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026